We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Clover Health Investments Corp (CLOV) USD0.0001 A

Sell:$3.23 Buy:$3.24 Change: $0.04 (1.25%)
NASDAQ:1.03%
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$3.23
Buy:$3.24
Change: $0.04 (1.25%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$3.23
Buy:$3.24
Change: $0.04 (1.25%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Clover Health Investments, Corp. is a physician-enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.

Contact details

Address:
3401 Mallory Lane, Suite 210, Suite 320
FRANKLIN
37067
United States
Telephone:
+1 (201) 4322133
Website:
https://www.cloverhealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CLOV
ISIN:
US18914F1030
Market cap:
$1.58 billion
Shares in issue:
501.11 million
Sector:
Managed Health Care
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Vivek Garipalli
    Executive Chairperson, Co-Founder
  • Andrew Toy
    Chief Executive Officer, Co-Founder, Director
  • Peter Kuipers
    Chief Financial Officer
  • Brady Priest
    Chief Executive Officer of Home Care
  • Jamie Reynoso
    Chief Executive Officer of Medicare Advantage
  • Aric Sharp
    Chief Executive Officer of Value-Based Care
  • Conrad Wai
    Chief Technology Officer
  • Karen Soares
    General Counsel, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.